Patents
Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
07/2000
07/05/2000CN1259138A 17 'beta'-allyloxy (thio) alkyl-androstane derivatives for the modulation of meiosis
07/05/2000CN1054133C 17-spiromethylene steroids
06/2000
06/29/2000DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases
06/27/2000US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
06/22/2000WO2000011017A9 Cardenolide complexes useful as cardioactive agents
06/15/2000WO2000034307A1 Sterol phosphates used as deodorant substances
06/13/2000CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates
06/08/2000DE19855956A1 Sterolphosphate Sterolphosphate
06/06/2000US6072068 Treating glucocorticoid-dependent diseases or symptoms
05/2000
05/31/2000EP1003842A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
05/31/2000EP1003553A1 The use of angiostatic steroids in photodynamic therapy
05/10/2000CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base
05/09/2000US6060598 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
05/09/2000US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer
05/02/2000US6057310 Organoselenium compounds with pro-oxidant activity and pharmaceutical use thereof
04/2000
04/26/2000EP0994884A1 Diphosphonic acid salts for the treatment of osteoporosis
04/26/2000CN1051762C Vitamin D3 analogs, preparation method and use, and medicinal composition containing same
04/25/2000CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids
04/04/2000US6046185 6,7-oxygenated steroids and uses related thereto
03/2000
03/29/2000EP0988312A1 17$g(b)-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
03/29/2000EP0602123B1 Steroid sulphatase inhibitors
03/28/2000US6043236 Especially preferred for the treatment of rheumatoid arthritis (ra) and multiple sclerosis (ms).
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/15/2000EP0984980A1 20-ARALKYL-5$g(a)-PREGNANE DERIVATIVES
03/15/2000EP0533703B1 Use of steroids for the inhibition of angiogenesis
03/14/2000US6037339 C-11 substituted steroids for treating menopausal complaints
03/02/2000WO2000011017A2 Cardenolide complexes useful as cardioactive agents
02/2000
02/10/2000WO2000006585A1 Medicine nitrate salts
02/10/2000CA2338912A1 Medicine nitrate salts
01/2000
01/26/2000EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
01/25/2000US6017904 Steroid sulphatase inhibitors
01/05/2000EP0969012A2 Process for preparing delta 9,11 and 21-chloro corticosteroids
01/05/2000EP0969011A2 Process for preparing delta 9,11 and 21-chloro corticosteroids
01/05/2000EP0763054B1 Process for preparing delta 9,11 and 21-chloro corticosteroids
12/1999
12/14/1999US6001825 Use of novel organoselenium compounds as pro-oxidizing agents their methods of preparation and pharmaceutical compositions and application thereof
11/1999
11/25/1999DE19823677A1 Verfahren zur Herstellung von 4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol und Zwischenprodukte im Verfahren (I) A process for the preparation of 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol, and intermediates in the process (I)
11/24/1999EP0633893B1 17-substituted steroids useful in cancer treatment
11/24/1999CN1046735C Steroids for treating menopausal complaints
11/23/1999US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula
11/17/1999CN1046502C 22-thiavitamin D3 derivative
11/16/1999US5985566 Detectable labels
11/02/1999US5977096 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
10/1999
10/26/1999US5972922 Steroids which inhibit angiogenesis
10/21/1999WO1999052930A1 METHOD FOR PRODUCING 4,4-DIMETHYL-5α-CHOLESTA-8,14,24-TRIENE-3β-OL AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD
10/06/1999EP0946583A1 Bissteroidal compounds and their use for the preparation of chiral complexes
09/1999
09/28/1999US5958901 Delivery of anionic macromolecules into cells.
09/16/1999DE19817520C1 Preparation of 4,4-dimethyl-5-alpha-cholesta-8,14,24-trien-3-beta-ol useful as meiosis regulator for the promotion of fertility
08/1999
08/24/1999US5942634 A drug delivery for gene therapy comprising a di-polyalkylamine-alkylamide or alkyl disulfide cholesterol
08/18/1999CN1226253A Steroid bisphosphonates
08/17/1999US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
08/17/1999CA2034042C Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
08/04/1999CN1044476C Chelate and preparation thereof
07/1999
07/28/1999EP0931047A1 Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
07/27/1999US5929262 Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
07/07/1999EP0927180A1 Heterocyclic compounds and their use for isolating nucleic acids
07/07/1999CN1222159A 6,7-oxygenated steroids and uses related thereto
07/06/1999US5919922 Fluorescent dyes free of aggregation and serum binding
07/01/1999WO1999032506A1 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES
07/01/1999WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension
06/1999
06/22/1999US5914325 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
06/10/1999WO1999028336A1 METHOD OF PREPARING 16α,17α-DIALKYLATED STEROIDS
06/10/1999CA2299396A1 Method of preparing 16.alpha.,17.alpha.-dialkylated steroids
05/1999
05/26/1999EP0917534A2 6,7-oxygenated steroids and uses related thereto
05/06/1999EP0912599A1 Diglycerid and sterol based organometallic complexes and pharmaceutical compositions and dietetic products containing them
05/06/1999EP0912598A1 Steroid bisphosphonates
05/06/1999EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes
04/1999
04/22/1999WO1999019342A1 Bile acid salts of metals with physiological action and the use thereof in therapy
04/08/1999WO1999016786A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds
04/07/1999EP0906332A1 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS
04/07/1999CN1212966A Usage of steroi saponin for preventing and curing senile dementia and new steroid saponin
03/1999
03/24/1999CA2216334A1 Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof
03/16/1999US5883271 2-Substituted vitamin D derivatives
03/10/1999EP0900234A1 21-substituted progesterone derivatives as new antiprogestational agents
03/09/1999US5880287 Polyoxyhydrocarbyl related products and methods for fluorescence assays
02/1999
02/25/1999WO1999009050A1 Transition metal and lewis acid complexes with steroid-receptor binding agents, in particular catechol estrogens
02/11/1999WO1999006536A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
02/11/1999CA2299623A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
02/04/1999WO1999005094A1 Novel compositions for the delivery of negatively charged molecules
02/04/1999CA2300695A1 Novel compositions for the delivery of negatively charged molecules
02/03/1999EP0721461B1 Synthesis of 17-(3-pyridyl) steroids
01/1999
01/28/1999WO1999003503A1 The use of angiostatic steroids in photodynamic therapy
01/28/1999CA2296558A1 The use of angiostatic steroids in photodynamic therapy of ocular neovascularization
01/26/1999CA1340342C 17-arylsteroids, process and intermediates for preparing the same, use therof as therapeutic agents and pharmaceutical compositions containing them
01/21/1999WO1999002539A1 Diphosphonic acid salts for the treatment of osteoporosis
01/21/1999CA2303210A1 Salts of diphosphonic acids and amino-alcohols for the treatment of osteoporosis
01/19/1999US5861390 Treatment of breast cancer
12/1998
12/29/1998US5854235 17-spiromethylene steroids
12/22/1998US5852182 Thiol-derivatized oligonucleosides
12/22/1998US5852005 Tetracyclic triterpenes
12/10/1998WO1998055498A1 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
12/10/1998CA2289524A1 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
12/09/1998EP0882062A1 Method of preparing 21-alkylated pregna-1,4,16-trien-3,20-diones
12/09/1998CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors
11/1998
11/26/1998WO1998052965A1 20-ARALKYL-5α-PREGNANE DERIVATIVES
11/26/1998CA2289675A1 20-aralkyl-5.alpha.-pregnane derivatives
11/24/1998US5840735 Estrogen
11/12/1998WO1998050417A1 Cationic amphiphiles containing a disulphide linker for cell transfections
11/11/1998CN1198816A Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/1998
10/20/1998US5824811 22-Thiavitamin D3 derivatives
10/06/1998US5817648 Vitamin D3 analogues having an unsaturated side chain
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16